Navigation Links
Gene therapy study shows safety and statistically significant improvement in Parkinson's disease

Neurologix, Inc. (OTC Bulletin Board: NRGX) today announced the publication in the June 23 issue of the journal The Lancet of positive results from the first ever gene therapy trial for Parkinson’s disease and the first report of direct gene transfer into a patient’s own brain cells for any adult neurodegenerative disease.

The open label Phase 1 study, conducted in 12 patients with advanced Parkinson’s disease demonstrated both a lack of adverse events related to the gene therapy procedure and statistically significant improvements from baseline in both clinical symptoms and abnormal brain metabolism (as measured by positron emission tomography, or PET scanning). Although all patients had symptoms on both sides of the body, the procedure was performed on only one side of the brain, enabling the untreated side to serve as a study control. The reported improvements were observed primarily on the treated side of the body beginning three months after the gene therapy procedure and persisted through the 12 months formal study period.

Neurologix sponsored the study as part of its ongoing efforts to develop this and other gene therapy approaches to the treatment of neurodegenerative and metabolic diseases. Principal investigators Michael G. Kaplitt, MD, PhD, and Matthew J. During, MD, PhD, performed the procedures at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. Andrew Feigin, MD and David Eidelberg, MD of the Feinstein Institute for Medical Research, North Shore-Long Island Jewish Health System performed the clinical evaluations and the PET scans. Neurologix scientists were also co-investigators in the study.

“This ground-breaking study represents not only an encouraging first step in the development of a promising new approach to Parkinson’s disease therapy, but also provides a platform to translate a variety of new gene therapy agents into human clinical trials for many devastating brain disorders,” said Paul Greengard, PhD,
'"/>

Source:JKureczka@comcast.net


Page: 1 2 3 4

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Columbia research lifts major hurdle to gene therapy for cancer
3. Combination therapy boosts effectiveness of telomere-directed cancer cell death
4. Gene therapy converts dead bone graft to new, living tissue
5. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
8. New therapy for HIV/AIDS eliminates needles and excessive toxicity
9. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
10. Gene therapy for Parkinsons disease moves forward in animals
11. Pulsating ultrasound enhances gene therapy for tumors
Post Your Comments:
(Date:7/3/2008)...utch ecologist Marijke van Kuijk has studied the r...ndoned agricultural land does regenerate to tropic...d to help nature along: pruning of foliage to free...species. Van Kuijk used the PHOLIAGE model to calc... tropics depend heavily on the products and servic...
(Date:7/3/2008)..., The problem with antibiotics is that, eventuall...t by targeting the gene that confers such resistan... Rockefeller University scientists tested the new ...dliest strains of multidrug-resistant Staphylococc...or the great majority of staphylococcal infections...
(Date:7/2/2008)...rlington, Virginia (July 2, 2008) Led by a bold c...ustrial powers have the opportunity at the upcomin...tive action against climate change. , German Cha...on Euros over four years to conserve tropical fore...st protection, starts to address a major source of...
(Date:7/2/2008)..., TALLAHASSEE, Fla. -- A Florida State University...to evaluate a new class of cancer-killing drugs is...hers. , Kevin C. Chen, an assistant professor of...a A&M University-Florida State University College ... determine how substances known as recombinant imm...
Breaking Biology News(10 mins):Giving nature a helping hand 2New antibiotic beats superbugs at their own game 2G8 summit: Opportunity for immediate action on climate change 2G8 summit: Opportunity for immediate action on climate change 3FSU researcher using computers to hone cancer-fighting strategies 2JAMA Article Provides False Support for CDCs Do Nothing Position on MRSA 14096 1JAMA Article Provides False Support for CDCs Do Nothing Position on MRSA 14096 2Super Bowl Champion Eli Manning Challenges Nation to Be Active 14093 1Study Finds Broadband Access Key to Empowerment of Minority Communities 3881 1Study Finds Broadband Access Key to Empowerment of Minority Communities 3881 2Mettler Toledo International Inc Announces Webcast of Presentation at Lehman Brothers Global Healthcare Conference 14086 1
... Proteins are the puzzle-pieces of life, involved ...heir complex biological processes in living system...mists and neurobiologists led by Timothy Dore at t...e California Institute of Technology has found a w...pecific locations. , The new method, which uses s...
... In a study expected to greatly benefit crop plant...- and seed-dwelling bacterium that protects plants...better explain how the helpful microbe, Pseudomona... seeds from infection by harmful microbes that cau...hed in Nature Biotechnology and was scheduled to b...
... Scientists at Harvard Medical School (HMS) have r...rax toxin into human cells. The work, which grew o...x therapeutic, shows that the protective antigen c...le in transferring the other two components of the...led by R. John Collier, professor of microbiology ...
... A geologist from Washington University in St. Lou...oherent story of how primitive life arose and dive... Blank Ph.D., Washington University assistant prof...; Sciences, has some insight concerning terrestria...ons about the nature of life on Mars and other pla...
Other Biology News:Protein synthesis can be controlled by light, opening way for new scientific, medical applications 2Protein synthesis can be controlled by light, opening way for new scientific, medical applications 3Genome study of beneficial microbe may help boost plant health 2Critical step traced in anthrax infection 2Map of life on Earth could be used on Mars 2Map of life on Earth could be used on Mars 3
(Date:7/2/2008)...es based on cells manufactured from bone marrow...und, SALT LAKE CITY and HAMBURG, Germany, July 2 ...pany at the forefront of innovative cell therapies...nnounced the closing of a,$14.5MM Series A financi...o,A/S joining the syndicate., "This financing rep...
(Date:7/2/2008)...s Pharma, a leading provider of,knowledge manageme...cience,industry, announced today that the Aureus P... October 23rd and 24th., This symposium follows l... was attended by many of Aureus, pharmaceutical an...rica. The symposium included presentations,from in...
(Date:7/2/2008)...n of Expanded Portfolio of Vascular ...umbia, July 2 /- Neovasc Inc. (TSXV:,... a company developing and,marketing innovative spe...change and the expansion of its product portfolio,...ascular product development companies and the,clos...
(Date:7/2/2008)...e-treatment R2 levels as a possible ...uly 2 / Lorus Therapeutics ...ation"), a biopharmaceutical company,specializing ...products and,technologies for the management of ca... University (OSU) clinical team of a paper entitle...
Breaking Biology Technology:AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 2AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 3Aureus Pharma Announces Date of 2008 Annual User Symposium 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 3Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 4Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 2Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 3Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 4Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 5
...urce: www.croquetproject.org Madison, Wis. The...e is the latest partner in the development of the...unications framework. , ,The company announced on ...t has begun developing software for the Croquet sy...commercial avenues. , ,What were doing here is ver...
...e Wisconsin Department of Justice, in the process ...tion throughout the state, has chosen a vendor to ... Inc. , a Chicago-based developer of XML-based net...rtment,s service-based architecture, called eTIME....stem during a period of transition. , ,The departm...
...rne Chapman, CIO of American Family When Byrne Ch...y wasnt one of the variations he imagined. Yet the...taken him in just that direction. Byrne Chapmans o...m data from the national weather service. , ,They ...tch the predictions to the locations of their poli...
...ison, Wis. Accessibility technology developed by...rch and Development Center will help people use t...centers to send packages this December. , ,The goa...g and supplementing the interface that was there t...derheiden, the director of the Trace center. , ,Th...
Other Biology Technology:UW open-source 3D environment tapped for commercial development 2American Family CIO takes entrepreneurial approach to innovation 2American Family CIO takes entrepreneurial approach to innovation 3American Family CIO takes entrepreneurial approach to innovation 4UW Trace center makes sending packages accessible to all 2
The BIOLASE Core Kit contains all the necessary components to perform polymerase assays on a wide range of DNA templates. In addition to dNTPs, the Core Kit is based on our widely used BIOLASE DNA po
Chicken Aortic Smooth Muscle Cells (CAOSMC) (>500,000 cells)
Human Pathogenic Viruses The National Collection of Pathogenic Viruses (NCPV) preserves well characterised, authenticated human pathogenic viruses in a secure facility, and NCPV is able to supply the
...a high performance spectral scanning multimode rea...e advanced SkanIt Software it offers superior flex...evelopment. Varioskan provides unlimited wavelengt...ved fluorescence and photometric assays and a disp...
Biology Products: